4 results about "Cremastra appendiculata" patented technology

This invention relates to a traditional Chinese medicine composition for treating primary liver cancer. The composition is made from the following raw materials in parts by weight: 25-30 parts of *Codonopsis pilosula*, 10-15 parts of *Cremastra appendiculata*, 15-20 parts of *Scutellaria barbata*, 20-25 parts of *Curcuma zedoaria*, 10-15 parts of *Polygonum cuspidatum*, and 5-10 parts of *Citrus reticulata*. This invention also provides applications of the traditional Chinese medicine composition. The "Liver-Clearing Formula" of this invention uses a combination of various traditional Chinese herbs, focusing on "damp-heat, phlegm, qi stagnation, and blood stasis." The six herbs are combined to both attack and tonify, supporting the body's resistance and eliminating pathogenic factors, aiming to achieve the goal of strengthening the body's resistance and reducing pathogenic factors, thus achieving the effects of clearing heat and dampness, promoting qi circulation, resolving phlegm, and breaking up blood stasis. This helps improve the patient's quality of life and prognosis. At the same time, the use of this traditional Chinese medicine is expected to reduce the toxicity and enhance the efficacy of Western medicine, reducing adverse reactions and achieving the best therapeutic effect.

This invention provides a traditional Chinese medicine preparation for treating Hashimoto's thyroiditis and its preparation method, belonging to the field of traditional Chinese medicine pharmaceutical technology. The preparation is made from Curcuma zedoaria, oyster shell, Eclipta prostrata, Ligustrum lucidum, Sargassum, processed Aconitum carmichaelii, Cremastra appendiculata, Duchesnea indica, Hedyotis diffusa, Artemisia capillaris, Oroxylum indicum, and cinnamon. The formula is meticulously formulated, closely addressing the core pathogenesis of Hashimoto's thyroiditis: "phlegm and blood stasis, spleen and kidney deficiency, and nutritional imbalance." It focuses on "eliminating masses and dispersing nodules, promoting qi and blood circulation," fully embodying the TCM diagnostic and treatment approach of "differentiating syndromes and treating accordingly, addressing both the root cause and symptoms." This invention's preparation has a good therapeutic effect on Hashimoto's thyroiditis, effectively improving thyroid autoimmune disorders, regulating thyroid function, and alleviating symptoms of local thyroid inflammation in experimentally induced Hashimoto's thyroiditis rats. Further clinical observation studies have found that this preparation significantly improves the overall effective rate of clinical treatment for Hashimoto's thyroiditis patients, providing a new approach to the treatment of this condition.

The traditional Chinese medicine composition comprises the following raw materials in parts by weight: 0.5 part of radix saposhnikoviae, 0.5 part of dandelion, 0.5 part of honeysuckle flower, 0.5 part of prepared kusnezoff monkshood root, 0.5 part of radix angelicae pubescentis, 0.5 part of angelica sinensis, 0.5 part of rheum officinale, 0.5 part of lindera aggregata, 0.5 part of radix sophorae flavescentis, 0.5 part of radix paeoniae rubra, 0.5 part of radix angelicae, 0.5 part of ground beeltle, 0.5 part of radix euphorbiae lantu, 0.5 part of gallnut, 0.5 part of asarum, 0.5 part of edible tulip, 0.5 part of oyster, 0.5 part of pollen typhae, 0.5 part of notopterygium root, 0.5 part of rhizoma bletillae and 0.5 part of ligusticum wallichii. The traditional Chinese medicine composition disclosed by the invention can be prepared into ointment after being decocted and taken according to the weight ratio, has the functions of relieving pain, stopping bleeding, promoting blood circulation, removing blood stasis, diminishing swelling, removing stasis and the like, and is good in fracture treatment effect, rapid in healing and high in cure rate.

This invention discloses a traditional Chinese medicine composition for treating lung cancer, prepared from the following raw materials in parts by weight: 15-30 parts of raw Astragalus membranaceus, 10-15 parts of Adenophora stricta, 10-15 parts of Asparagus cochinchinensis, 10-15 parts of Ophiopogon japonicus, 10-15 parts of Poria cocos, 15-30 parts of Selaginella tamariscina, 15-30 parts of Hedyotis diffusa, 15-30 parts of Paris polyphylla, 15-30 parts of Cremastra appendiculata, 15-30 parts of Prunella vulgaris, 15-30 parts of Houttuynia cordata, and 10-15 parts of Ligustrum lucidum. This traditional Chinese medicine composition can inhibit the proliferation of lung cancer cells and promote their apoptosis. Simultaneously, it exerts an anti-invasion and metastatic effect on lung cancer by intervening in exosomes, improving clinical symptoms in cancer patients, regulating functional immune function, and improving quality of life.